Cell Therapy

Deal marks entry into next-generation CAR-T cancer therapies as company expands global innovation ambitions

Immuneel Therapeutics, backed by entrepreneur Kiran Mazumdar-Shaw, offers therapy for CAR T-cell therapy for adult B-cell non-hodgkin lymphoma (B-NHL)

Speaking at the launch event, Murmu said indigenous development of the therapy was an example of the Make in India initiative

CAR-T therapy is seen to be on the verge of a breakthrough, raising hopes for both cancer patients as well as medical tourism. But can it become the first line of treatment?

TMS Ep627: Uniform Civil Code, insurtech, markets, CAR-T cell therapy

How will Uttarakhand's UCC change things? Can insurtech drive up insurance penetration in India? Will Sebi's new disclosure norms affect FII flows? What is CAR-T cell therapy? All answers here

One injection will cost Rs 1.25 lakh with effects lasting for two years or more

Pharma firms and start-ups working to launch it within 2 yrs

Laurus labs investment in ImmunoACT is part of the larger strategy to strengthen biologics business of the firm

They said this disease can cause inflammation of heart muscle if left untreated, and is the leading cause of acquired heart disease in children in developed nations

Putting aside prices for a moment, it's been an exciting period for medical progress

Start-up in talks with MNCsto out-license Ossgrow for developed markets